Antitumor Activity With Belzutifan in Advanced Clear Cell… : Oncology Times
An abstract is unavailable.
An abstract is unavailable.
An abstract is unavailable.
Major Finding: A pan-cancer resource was developed that identifies the presence and relevance of the metastatic microbiome. Approach: Multi-omic analyses were conducted on 4,160 metastatic…
Amandeep Salhotra, MD, discusses the feasibility and safety of Orca-T graft in patients undergoing allogeneic transplant for hematologic malignancies.
As part of its Speaking Out video series, Targeted Oncology spoke with Howard D. Edington, MD, about the benefits of using oncolytic viruses in cancer…
Wolters Kluwer (“we” or “us”) wants to inform you about the ways we process your personal information. In this Privacy & Cookie Notice we explain…
Peritoneal cancer is a rare cancer that develops in the peritoneum and shares characteristics of ovarian cancer. Here, gynecologic oncologist Roni Nitecki Wilke, M.D., answers…
Alexander Kutikov, MD, FACS, discusses treatment options for patients with urothelial cancer requiring cystectomy.
Major Finding: IDH-mutant low-grade gliomas that respond to IDH inhibition undergo lineage differentiation. Concept: Glioma cell fate is shifted towards differentiation and away from a…
35 patients were prospectively enrolled to participate and received questionnaires with sequential clinical visits monitoring treatment of their developmental dysplasia of the hip. One-sample Student…